Cargando…
Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes
INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has emerged as a major cause of morbidity and mortality worldwide, placing unprecedented pressure on healthcare. Cardiomyopathy is described in patients with severe COVID-19 and increasing evidence suggests...
Autores principales: | Jakobi, Tobias, Groß, Julia, Cyganek, Lukas, Doroudgar, Shirin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170897/ https://www.ncbi.nlm.nih.gov/pubmed/35686037 http://dx.doi.org/10.3389/fcvm.2022.844441 |
Ejemplares similares
-
Editorial: Cardiac Microvascular Endothelium Contribution to Cardiac Myocyte Growth, Structure, and Contractile Function
por: Altara, Raffaele, et al.
Publicado: (2019) -
Proteomic analysis of the cardiac myocyte secretome reveals extracellular protective functions for the ER stress response
por: Blackwood, Erik A., et al.
Publicado: (2020) -
Mutations in genes related to myocyte contraction and ventricular septum development in non-syndromic tetralogy of Fallot
por: Harvey, Drayton C., et al.
Publicado: (2023) -
Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in isolated mouse ventricular myocytes
por: Tarnowski, Daniel, et al.
Publicado: (2023) -
Editorial: Antithrombotic Treatment in Transcatheter Structural Cardiac Interventions and After Cardiac Device Implantation
por: Siller-Matula, Jolanta M., et al.
Publicado: (2020)